Valneva SE, a prominent biotechnology company headquartered in France, is dedicated to developing and commercialising innovative vaccines for infectious diseases. Founded in 2013, Valneva has rapidly established itself in the global vaccine industry, with significant operations across Europe and North America. The company focuses on creating unique vaccine solutions, including its flagship product, the inactivated vaccine for Lyme disease, which stands out for its advanced technology and efficacy. Valneva's commitment to addressing unmet medical needs has positioned it as a key player in the market, achieving notable milestones such as partnerships with leading pharmaceutical firms and successful clinical trials. With a strong emphasis on research and development, Valneva continues to drive advancements in vaccine technology, contributing to global health initiatives.
How does Valneva's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Valneva's score of 50 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Valneva reported total carbon emissions of approximately 59,000,000 kg CO2e, with emissions distributed across various scopes: 1,277,000 kg CO2e (Scope 1), 2,499,000 kg CO2e (Scope 2), and a significant 55,534,000 kg CO2e (Scope 3). The previous year, 2023, saw total emissions of about 4,751,000 kg CO2e, comprising 1,688,000 kg CO2e (Scope 1), 1,477,000 kg CO2e (Scope 2), and 1,586,000 kg CO2e (Scope 3). Valneva has made notable strides in reducing its carbon footprint, achieving a 48% reduction in CO2 emissions from gas and electricity since 2019, equating to a decrease of approximately 1,630 tonnes CO2e. The company has set ambitious targets to further reduce its emissions by 50% from a 2022 baseline by 2030 for both Scope 1 and Scope 2 emissions, focusing on its laboratories and manufacturing sites. Valneva's commitment to sustainability is evident through its shift to green electricity and ongoing initiatives aimed at minimising its environmental impact. The emissions data is sourced directly from Valneva SE, with no cascaded data from parent organisations.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 1,629,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 1,289,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | 0,000,000 | 00,000,000 |
Valneva's Scope 3 emissions, which increased significantly last year and increased significantly since 2023, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 63% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Valneva has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
